# Zhongmo Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhongmo-medical

- Industry: Healthcare
- Headquarters: Wuhan, China
- Latest round: Angel (Oct 14, 2025)
- Investors on record: 1

## About

Founded in 2019 and based in Wuhan, China, Zhongmo Medical is a biotechnology company focused on developing gene therapies for rare ophthalmic genetic diseases. In October 2025, Zhongmo Medical raised Angel funding from new investor Wuhan Jingkai Industrial Capital.
The company’s pipeline includes gene therapy drugs targeting juvenile retinoschisis and retinitis pigmentosa. Its lead candidate for retinoschisis has entered clinical trials, marking the first such program in China. Zhongmo Medical also develops supporting technologies for gene delivery and platform optimization.
Revenue is generated through licensing of gene therapy technologies, clinical partnerships, and eventual commercialization of ophthalmic gene therapy drugs. Additional income may come from R&D services and technology transfer agreements.

## Funding rounds

- Angel, Oct 14, 2025 — Wuhan Jingkai Industrial Capital

## Investors

- Wuhan Jingkai Industrial Capital (https://capitalatlas.ai/funds/wuhan-jingkai-industrial-capital) — Angel